Literature DB >> 17572457

Determinants of influenza and pneumococcal vaccination in elderly people: a systematic review.

Y Kohlhammer1, M Schnoor, M Schwartz, H Raspe, T Schäfer.   

Abstract

OBJECTIVES: Despite strong national and international recommendations on immunization practices, rates for influenza (IV) and pneumococcal vaccinations (PV) are low. We aimed to review international immunization rates and to analyze attitudes and beliefs regarding IV and PV. STUDY
DESIGN: Systematic review.
METHOD: The MEDLINE database search comprised articles from 1966 to October 2005. Fourteen surveys evaluating a total number of 49292 participants in nine different countries were included into the analysis.
RESULTS: Vaccination rates among risk groups do vary significantly between different countries, reaching highest rates in the USA (IV, 82%; PV, 71%) and lowest in former West-Germany for IV (37%) and in Israel for PV (20%). Recommendations by doctors play a central role in promoting IV and PV. The main reason for not being vaccinated was lack of information.
CONCLUSION: Specific strategies targeted at groups are needed to increase the knowledge of IV and PV, and thereby decrease incidences of acute lung diseases.

Entities:  

Mesh:

Year:  2007        PMID: 17572457     DOI: 10.1016/j.puhe.2007.02.011

Source DB:  PubMed          Journal:  Public Health        ISSN: 0033-3506            Impact factor:   2.427


  36 in total

1.  Determinants of influenza vaccination among a large adult population in Quebec.

Authors:  Geneviève Baron; Virginie Gosselin; Geneviève Petit; Maryse Guay; Arnaud Gagneur
Journal:  Hum Vaccin Immunother       Date:  2018-06-29       Impact factor: 3.452

2.  Impact of Race on Immunization Status in Long-Term Care Facilities.

Authors:  Stacey C Barrett; Stephen Schmaltz; Nancy Kupka; Kenneth A Rasinski
Journal:  J Racial Ethn Health Disparities       Date:  2018-07-12

Review 3.  Vaccine hesitancy: an overview.

Authors:  Eve Dubé; Caroline Laberge; Maryse Guay; Paul Bramadat; Réal Roy; Julie Bettinger
Journal:  Hum Vaccin Immunother       Date:  2013-04-12       Impact factor: 3.452

4.  Racial/Ethnic Disparities in Influenza and Pneumococcal Vaccinations Among Nursing Home Residents: A Systematic Review.

Authors:  Jasmine L Travers; Krista L Schroeder; Thomas E Blaylock; Patricia W Stone
Journal:  Gerontologist       Date:  2018-07-13

5.  Influenza vaccine uptake among community-dwelling Italian elderly: results from a large cross-sectional study.

Authors:  Carlos Chiatti; Pamela Barbadoro; Giovanni Lamura; Lucia Pennacchietti; Francesco Di Stanislao; Marcello M D'Errico; Emilia Prospero
Journal:  BMC Public Health       Date:  2011-04-01       Impact factor: 3.295

Review 6.  Interventions to increase influenza vaccination rates of those 60 years and older in the community.

Authors:  Roger E Thomas; Diane L Lorenzetti
Journal:  Cochrane Database Syst Rev       Date:  2014-07-07

Review 7.  Social determinants of health and seasonal influenza vaccination in adults ≥65 years: a systematic review of qualitative and quantitative data.

Authors:  Jason M Nagata; Isabel Hernández-Ramos; Anand Sivasankara Kurup; Daniel Albrecht; Claudia Vivas-Torrealba; Carlos Franco-Paredes
Journal:  BMC Public Health       Date:  2013-04-25       Impact factor: 3.295

8.  Standing orders for influenza and pneumococcal polysaccharide vaccination: correlates identified in a national survey of U.S. Primary care physicians.

Authors:  Steven M Albert; Mary Patricia Nowalk; Michael A Yonas; Richard K Zimmerman; Faruque Ahmed
Journal:  BMC Fam Pract       Date:  2012-03-20       Impact factor: 2.497

9.  Factors associated with influenza vaccine uptake in older adults living in the community in Singapore.

Authors:  L W Ang; J Cutter; L James; K T Goh
Journal:  Epidemiol Infect       Date:  2016-12-08       Impact factor: 4.434

Review 10.  Non-participation in population-based disease prevention programs in general practice.

Authors:  Berber Koopmans; Mark M J Nielen; François G Schellevis; Joke C Korevaar
Journal:  BMC Public Health       Date:  2012-10-09       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.